Diagram showing an antigen-presenting cells on the left, a T cell in the center, and a cancer cell on the right to illustrate the mechanism of action of Yervoy and Opdivo. Each of these drugs is an antibody that interferes with an immune checkpoint pathway in T cells. From Bristol Myers Squibb.